Joseph Aisner - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Joseph Aisner

Showing results (61-70 of 64) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 64 results.

Journal of the National Cancer Institute|November 21, 2017

Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2017

First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid TumorsMark N Stein, Joseph R Bertino, Howard L Kaufman, et al.

The Oncologist|August 28, 2016

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.

Journal for Immunotherapy of Cancer|May 24, 2019

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administrationMark N Stein, Jyoti Malhotra, Rohinton S Tarapore, et al.

Pageof 7

Search research articles

Showing results (61-70 of 64) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 64 results.

Journal of the National Cancer Institute|November 21, 2017

Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2017

First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid TumorsMark N Stein, Joseph R Bertino, Howard L Kaufman, et al.

The Oncologist|August 28, 2016

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.

Journal for Immunotherapy of Cancer|May 24, 2019

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administrationMark N Stein, Jyoti Malhotra, Rohinton S Tarapore, et al.

Pageof 7